International Stem Cell Corporation

International Stem Cell Corporation (ISCO) is a publicly traded biotechnology company with a powerful new stem cell technology called parthenogenesis, which uses unfertilized eggs and holds promise to significantly advance the field of regenerative medicine by addressing issues of immune rejection.They focus on using these stem cells to treat eye, nervous system, and liver diseases, where cell therapy has been clinically proven but is limited by the availability of safe, immune-matched human cells or tissues.